Treatment of Acute Myeloblastic Leukemia in Younger Patients

A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers

NCT05541224 ·Status: COMPLETED

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761 ·Status: TERMINATED ·Phase: PHASE2

RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML

NCT01307241 ·Status: UNKNOWN

Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.

NCT04311060 ·Status: NOT_YET_RECRUITING

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

NCT00497991 ·Status: COMPLETED ·Phase: PHASE1

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

NCT01491763 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

NCT05137860 ·Status: UNKNOWN ·Phase: PHASE4

Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia

NCT02353143 ·Status: TERMINATED ·Phase: PHASE1

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

NCT02010931 ·Status: COMPLETED

First Report, Five Years Experience of the Acute Leukemia Work Group

NCT02990104 ·Status: UNKNOWN

International Chronic Myeloid Leukemia Pediatric Study

NCT01281735 ·Status: RECRUITING

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT01550185 ·Status: TERMINATED ·Phase: PHASE1

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

NCT03080766 ·Status: UNKNOWN ·Phase: PHASE2

LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

NCT01198054 ·Status: TERMINATED ·Phase: PHASE4

Lenalidomide In Patients With Acute Myeloid Leukemia

NCT00839059 ·Status: TERMINATED ·Phase: PHASE1

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

NCT05619978 ·Status: COMPLETED

Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL

NCT06930105 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

NCT02903277 ·Status: UNKNOWN

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

NCT02113319 ·Status: COMPLETED ·Phase: PHASE2

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

NCT01578954 ·Status: COMPLETED ·Phase: PHASE1

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

NCT01242774 ·Status: COMPLETED ·Phase: PHASE1

Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)

NCT00840346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib

NCT01343173 ·Status: COMPLETED ·Phase: NA

Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation

NCT05611216 ·Status: COMPLETED

Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia

NCT05893836 ·Status: COMPLETED